Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

Urso (Ursodiol) 500 mg Tablets Approved in the U.S. for the Treatment of Primary Biliary Cirrhosis MONT SAINT-HILAIRE, QC -- July 26, 2004 -- Axcan Pharma Inc. ("Axcan" or the "Company") announced today that it has received approval from the U.S. Food and Drug Administration for the use of Urso in a 500 mg tablet dosage form, to be administered two to four times daily, for the treatment of Primary Biliary Cirrhosis ("PBC"). "We expect this new stronger dosage form for ursodiol to contribute to our continued penetration of the U.S. ursodiol market," stated Leon F. Gosselin, President and Chief Executive Officer of Axcan. "In addition, the new dosage form will allow patients the convenience of taking fewer tablets per day, with expected improved compliance," he concluded. In North America the ursodiol market exceeds U.S.$100 million annually. Axcan's North American sales of ursodiol products amounted to U.S.$47 million for fiscal 2003. During the twelve-month period ended May 31, 2004, 38.3% of all gastrointestinal prescriptions for ursodiol in the United States were for URSO 250, making URSO 250 the most prescribed brand of ursodiol in the U.S. PBC is a chronic liver disease that slowly destroys the bile ducts in the liver and eventually leads to cirrhosis. Cirrhosis results in severe liver scarring (fibrosis) that diminishes liver function. The cause of PBC is unknown. Studies show that women are affected 10 times more commonly than men. PBC is usually diagnosed in patients between the ages of 35 and 60. The illness is chronic and can lead to liver failure and other life-threatening complications. SOURCE: AXCAN PHARMA INC. E-mail this page to a friend or colleague! To print, use this version